Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trial.
Stuart J PocockJoao Pedro FerreiraJohn GregsonStefan D AnkerJaved ButlerGerasimos S FilippatosNicholas D GollopTomoko IwataMartina BrueckmannJames L JanuzziAdriaan A VoorsFaiez ZannadMilton PackerPublished in: European heart journal (2021)
The combination of NT-proBNP and hs-cTnT with a small number of readily available clinical variables provides prognostic assessment for patients with HFrEF. This predictive tool kit can be easily implemented for routine clinical use.